INVESTABOT
Equity Research
XNYS · LABORATORY ANALYTICAL INSTRUMENTS · LABORATORY ANALYTICAL INSTRUMENTS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Revvity (RVTY) had 1 Form 144 pre-sale notice filed on 2026-07-20. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 7/20/2026 | Gonzales Anita | Vice President and CAO | SELL | -85 | $109 | $9,306 |
| 6/15/2026 | Gonzales Anita | Vice President and CAO | TAX_WITHHOLD | -33 | $100 | $3,289 |
| 5/7/2026 | MICHAS ALEXIS P | — | GRANT | 1,217 | — | — |
| 5/7/2026 | MICHAS ALEXIS P | — | GRANT | 1,467 | — | — |
| 5/7/2026 | Vandebroek Sophie V. | — | GRANT | 1,015 | — | — |
| 5/7/2026 | Vandebroek Sophie V. | — | GRANT | 1,265 | — | — |
| 5/7/2026 | Klobuchar Michael A | — | GRANT | 1,015 | — | — |
| 5/7/2026 | Klobuchar Michael A | — | GRANT | 1,265 | — | — |
| 5/7/2026 | Witney Frank | — | GRANT | 1,015 | — | — |
| 5/7/2026 | Witney Frank | — | GRANT | 1,265 | — | — |
| 5/7/2026 | Chapin Samuel R. | — | GRANT | 1,015 | — | — |
| 5/7/2026 | Chapin Samuel R. | — | GRANT | 1,265 | — | — |
| 5/7/2026 | Vounatsos Michel | — | GRANT | 1,015 | — | — |
| 5/7/2026 | Vounatsos Michel | — | GRANT | 1,265 | — | — |
| 5/7/2026 | McMurry-Heath Michelle | — | GRANT | 1,015 | — | — |
| 5/7/2026 | McMurry-Heath Michelle | — | GRANT | 1,265 | — | — |
| 5/7/2026 | Witz Pascale | — | GRANT | 1,015 | — | — |
| 5/7/2026 | Witz Pascale | — | GRANT | 1,265 | — | — |
| 5/7/2026 | Barrett Peter | — | GRANT | 1,015 | — | — |
| 5/7/2026 | Barrett Peter | — | GRANT | 1,265 | — | — |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 13,160,897 | $1,273,316,785 | — | 1/29/2026 |
| BlackRock | 8,782,895 | $920,974,392 | — | 8/13/2024 |
| BlackRock | 7,658,369 | $852,070,090 | 5.6% | 8/7/2026 |
| BlackRock | 7,178,608 | $694,530,291 | — | 2/12/2026 |
| BlackRock | 7,250,376 | $635,205,478 | 1.0% | 5/13/2026 |
| State Street | 4,342,739 | $483,173,141 | 0.8% | 8/7/2026 |
| State Street | 4,310,246 | $417,016,301 | — | 2/13/2026 |
| State Street | 4,310,313 | $377,626,522 | 0.0% | 5/15/2026 |
| Morgan Stanley | 2,574,826 | $286,475,399 | -4.0% | 8/13/2026 |
| Morgan Stanley | 2,844,464 | $275,202,151 | — | 5/27/2026 |
| Morgan Stanley | 2,683,026 | $235,060,195 | -5.7% | 5/15/2026 |
| Citadel Advisors | 1,488,135 | $165,569,900 | 580.6% | 8/14/2026 |
| Millennium Management | 1,106,468 | $107,050,779 | — | 2/17/2026 |
| Goldman Sachs | 900,351 | $100,173,074 | 87.1% | 8/14/2026 |
| Goldman Sachs | 792,894 | $76,712,542 | — | 3/25/2026 |
| JP Morgan Chase | 481,955 | $54,177,057 | 21.5% | 8/12/2026 |
| Fidelity (FMR) | 465,642 | $51,807,384 | 33.3% | 8/13/2026 |
| Goldman Sachs | 481,255 | $42,162,746 | -39.3% | 5/15/2026 |
| JP Morgan Chase | 396,639 | $33,627,134 | 46.3% | 5/13/2026 |
| Fidelity (FMR) | 349,390 | $30,610,110 | 159.1% | 5/15/2026 |